Intrasense S.A. reported earnings results for the full year ended December 31, 2022. For the full year, the company reported sales was EUR 3.79 million compared to EUR 4.19 million a year ago. Net loss was EUR 3.42 million compared to EUR 1.2 million a year ago.
Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
0.324 EUR | +1.25% | +0.62% | -10.00% |
04-17 | Intrasense: an innovative solution for cancer monitoring | CF |
04-09 | Guerbet: CE certificate for a platform | CF |
1st Jan change | Capi. | |
---|---|---|
-10.00% | 18.21M | |
+12.15% | 227B | |
+14.90% | 197B | |
+18.22% | 141B | |
+29.15% | 110B | |
+1.06% | 64.15B | |
+16.92% | 53.72B | |
+6.33% | 51.75B | |
+10.93% | 45.2B | |
+5.87% | 37.37B |
- Stock Market
- Equities
- ALINS Stock
- News Intrasense
- Intrasense S.A. Reports Earnings Results for the Full Year Ended December 31, 2022